Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

The Public Health Impact of Direct-To-Consumer Advertising of Prescription Drugs

This report explores the public health impact of direct-to-consumer advertising based on a nationally representative sample of adults who discussed advertised drugs with their physicians. The report departed from an existing body of research, which evaluates attitudes and opinions, and instead examined actual healthcare experiences and outcomes. The research found that DTC prompted discussion between patients and their physicians, and prompted additional care by their physicians, including ordering new prescriptions. However, fewer than half of new prescriptions were for the drug that was advertised.

Newsletter Volume

E.V.I.dently October 2013

Message from NPCWhen Health Insurance Exchange “Dust” Settles, Usable CER Will Be CriticalBy Dan LeonardOn October 1, the debut of the federal...
Blog Post

Catch These Upcoming Events and Publications

September was a particularly busy month, featuring a variety of health care conferences, meetings, publications, and ongoing debates about the...
Blog Post

Leading Researchers Outline Principles for Planning & Conduct of CER

A new set of principles developed by a group of leading researchers could help to ensure more consistency in how comparative effectiveness research (...
YouTube Videos

A Translation Table for Patient-Centered CER

In this brief interview, Quintiles Outcome President Dr. Rich Gliklich explains the concept of a translation table, which aids in the selection of...
Press Release

National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.

Washington, DC (December 21, 2009) –The National Pharmaceutical Council (NPC) today announced that Otsuka America Pharmaceutical, Inc. has joined the...
Press Release

NBCH eValue8™ Report Reveals Health Plans’ Ability to Align Employee Incentives to Improve Health

Washington, DC (November 30, 2009) – The current rate of health care cost increases are unsustainable and health care purchasers are increasingly...
Press Release

New Study Shows that Pharmacogenomics Could Benefit Patients, Spur Investment in Innovation

Washington, DC. (July 31, 2009) – A new study funded by the National Pharmaceutical Council (NPC) shows that pharmacogenomics – the field of...
Commentary and Testimony Page

Medicare Part D, Adherence, and the Value of Pharmaceuticals

Before enactment of the health care reform legislation two years ago, the most significant change in the health care landscape over the past decade...
Commentary and Testimony Page

Health Care Reform and Pharmaceutical Innovation

Although the Patient Protection and Affordable Care Act of 2010 (PPACA) is expected to have broad societal benefits, moving forward, it will be...
Commentary and Testimony Page

Comments on “The NCCN Comparative Therapeutic Index TM as a Paradigm

The National Pharmaceutical Council (NPC) appreciates this opportunity to comment on the proposed “The NCCN Comparative Therapeutic Index ™ as a...
Commentary and Testimony Page

Congress Looks at Public vs. Public-Private CER Entity

As part of the ongoing congressional health care reform debate, there are several competing proposals regarding the creation of a comparative...
YouTube Videos

A Translation Table for Patient-Centered CER

In this brief interview, Quintiles Outcome President Dr. Rich Gliklich explains the concept of a translation table, which aids in the selection of...
YouTube Videos

Data Mining and Individual Treatment Effects

Dr. Robert Epstein, former chief medical officer and senior vice president of medical affairs at Medco Health, explains how the growth in the use of...
YouTube Videos

CER and HTA: A View From the UK

Dr. Michael Drummond, professor of Health Economics at the University of York, UK, explains the differences between health technology assessments (...
YouTube Videos

Patient Views on Communicating CER Findings

Stephen Hume, PsyD, Alzheimer's Patient Representative, and his care partner, Candace Darcy, explain the challenges they face in seeking out...
Blog Post

Catch These Upcoming Events and Publications

September was a particularly busy month, featuring a variety of health care conferences, meetings, publications, and ongoing debates about the...
Blog Post

Leading Researchers Outline Principles for Planning & Conduct of CER

A new set of principles developed by a group of leading researchers could help to ensure more consistency in how comparative effectiveness research (...
Blog Post

NPC Research Highlighted at Academy Health's Annual Research Meeting

NPC’s collaborative research, “What is the Real World Impact of Comparative Effectiveness Research (CER) Findings on Utilization?” will be...
Blog Post

Principles for the Conduct of Comparative Effectiveness Research

Several researchers and stakeholders are developing a set of principles about what constitutes good comparative effectiveness research (CER)...

Research

The Myth of Average: Why Individual Patient Differences Matter

Within today’s health care environment, so much of t

The Productivity Crisis in Pharmaceutical R&D

Although investment in pharmaceutical R&D has increased substantially in this time, the lack of...
  •  
  • 1 of 4
  • >

Commentary & Testimony